Sartorius, 1425-050, CellGenix® rh IFN-γ (Preclinical Grade)

Optimal use for maturation of monocyte-derived dendritic cells (Mo-DCs) and generation of CIKs
Recombinant Human Interferon-gamma
ADCF Level 2
High purity to ensure the safety of your process
Endotoxin Level ≤ 1000 EU/mg

CellGenix® Preclinical Recombinant Human Interferon-gamma (IFN-γ) is an animal-derived component-free product. It is produced in a dedicated animal-free GMP facility.
IFN-γ is used in the cell and gene therapy space for the ex vivo maturation of monocyte-derived dendritic cells (Mo-DCs), ex vivo generation of cytokine induced killer cells (CIK cells) and stimulation of monocytes, macrophages and microglia.
Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.
Please access the Certificate of Analysis on the My Sartorius Portal.
Expiry: 3 years from date of shipping

Specifications
Applications:
Application Area: Cell & gene therapy; Immunology
Cell Type: DC; Neuronal Cells
Intended Use: Preclinical ex vivo use

Biological Information:
Activity: ≥ 10 x 106 IU/mg

Compliance Information:
Origin: Animal-Component Free
Quality Grade: Preclinical

Features:
Carrier-Protein Free: Yes

Physicochemical Information:
Endotoxin: ≤ 1 EU/µg
Expression System: E. coli
Formulation: Lyophilized from a 0.2 µm-filtered solution containing 20 mM succinate, pH 5.0

Product Information:
Brand: CellGenix®
Package Type: Vial
Size: 50 µg

Sterility/Purity:
Delivery Condition: Sterile
Purity: ≥ 95%

Weight:
Molecular Weight (kDa): 16.5 kDa